Open AccessMale infertility treatments: clinical overview
Author(s) -
И. А. Корнеев
Publication year - 2019
Publication title -
medicinskij sovet
Language(s) - English
Resource type - Journals
eISSN - 2658-5790
pISSN - 2079-701X
DOI - 10.21518/2079-701x-2019-13-99-104
Subject(s) - dna fragmentation , infertility , sperm , pregnancy rate , male infertility , adverse effect , andrology , sperm motility , pregnancy , gynecology , medicine , reproductive technology , biology , obstetrics , genetics , apoptosis , lactation , programmed cell death
The article provides an overview of studies of antioxidant properties of the components contained in AndroDoz, as well as the results of using AndroDoz biocomplex, due to which infertile men showed an increase in concentration, motility and percentage of sperm with a normal form in the ejaculate, a decrease in sperm DNA fragmentation and an increase in pregnancy rates after using assisted reproductive technologies, as well as getting pregnant naturally. Due to absence of adverse events and side effects, AndroDoz can be recommended to a wide range of patients with pathozoospermia and idiopathic infertility.